Senior insider sale
Chairman, President & CEO at INTRA-CELLULAR THERAPIES, INC. — senior position signals high conviction
$8.72M
102.70K shares
What this filing means
MATES SHARON plans to sell 102.70K shares of INTRA-CELLULAR THERAPIES, INC. valued at approximately $8.72M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/5/2024ACC: 0001971857-24-000785
DirectorOfficer· Chairman, President & CEO
Since Dec 2018
102.70K
Shares to sell
$8.72M
Approx. market value
172.70K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
compensation
compensation
1/8/2019
172.70KTotal acquired172.70K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/8/2019 | compensation compensation | 172.70K | — |
| Total | 172.70K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
51K
Market value
$4.37M
12/4/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
51.70K
Market value
$4.34M
12/5/2024
Total
Units
102.70K
Value
$8.72M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/4/2024 | 51K | $4.37M | — | Completed |
| Planned — Approximate Date | ||||
12/5/2024 | 51.70K | $4.34M | NASDAQ | Planned |
| Total | 102.70K | $8.72M | ||